1International Diabetes Federation (2017) IDF Diabetes Atlas, 8th ed. Brussels: International Diabetes Federation.
2.Vasan, SK, Pittard, AE, Abraham, J, et al. (2012) Cause-specific mortality in diabetes: retrospective hospital based data from south India. J Diabetes 4, 47–54.
3.Khunti, K, Gavin, JR III, Boulton, AJM, et al. (2018) The Berlin Declaration: a call to improve early actions related to type 2 diabetes. Why is primary care important? Prim Care Diabetes 12, 383–392.
4.Lean, ME, Leslie, WS, Barnes, AC, et al. (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541–551.
5.Kapoor, N, Furler, J, Paul, TV, et al. (2019) Ethnicity-specific cut-offs that predict co-morbidities: the way forward for optimal utility of obesity indicators. J Biosoc Sci 51, 624–626.
6.Yoon, KH, Lee, JH, Kim, JW, et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368, 1681–1688.
7.Kapoor, N, Furler, J, Paul, TV, et al. (2019) The BMI–adiposity conundrum in South Asian populations: need for further research. J Biosoc Sci 51, 619–621.
8.Afshin, A, Forouzanfar, MH, Reitsma, MB, et al. (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377, 13–27.
9.Yajnik, CS & Yudkin, JS (2004) The Y-Y paradox. Lancet 363, 163.
10.Kurpad, AV, Varadharajan, KS & Aeberli, I (2011) The thin–fat phenotype and global metabolic disease risk. Curr Opin Clin Nutr Metab Care 14, 542–547.
11.Eknoyan, G (2008) Adolphe Quetelet (1796–1874) – the average man and indices of obesity. Nephrol Dial Transplant 23, 47–51.
12.India State-Level Disease Burden Initiative Diabetes Collaborators (2018) The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Global Health 6, e1352–e1362.
13.Sathish, T, Williams, ED, Pasricha, N, et al. (2013) Cluster randomised controlled trial of a peer-led lifestyle intervention program: study protocol for the Kerala Diabetes Prevention Program. BMC Public Health 13, 1035.
14.American Diabetes Association, (2017) 2. Classification and diagnosis of diabetes. Diabetes Care 40, S11–S24.
15.Beeson, WL, Batech, M, Schultz, E, et al. (2010) Comparison of body composition by bioelectrical impedance analysis and dual-energy X-ray absorptiometry in Hispanic diabetics. Int J Body Compos Res 8, 45–50.
16.Bonita, R, Winkelmann, R, Douglas, KA, et al. (2003) The WHO stepwise approach to surveillance (STEPS) of non-communicable disease risk factors. In Global Behavioral Risk Factor Surveillance, pp. 9–22 [McQueen, D and Puska, P, editors]. New York: Springer.
17.Hillis, SL & Berbaum, KS (2004) Power estimation for the Dorfman–Berbaum–Metz method. Acad Radiol 11, 1260–1273.
18.Nimptsch, K, Konigorski, S & Pischon, T (2019) Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. Metabolism 92, 61–70.
19.Kapoor, N, Furler, J, Paul, TV, et al. (2019) Normal weight obesity: an underrecognized problem in individuals of South Asian descent. Clin Ther 41, 1638–1642.
20.Wannamethee, SG, Papacosta, O, Whincup, PH, et al. (2010) Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women. Diabetologia 53, 890–898.
21.Xin, Z, Liu, C, Niu, WY, et al. (2012) Identifying obesity indicators which best correlate with type 2 diabetes in a Chinese population. BMC Public Health 12, 732.
22.The Diabetes Prevention Program Research Group (2006) Relationship of body size and shape to the development of diabetes in the Diabetes Prevention Program. Obesity (Silver Spring) 14, 2107–2117.
23.Anonymous, (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. National Institutes of Health. Obes Res 6, Suppl. 2, 51s–209s.
24.Bray, GA (1998) In defense of a body mass index of 25 as the cut-off point for defining overweight. Obes Res 6, 461–462.
25.Klein, S, Allison, DB, Heymsfield, SB, et al. (2007) Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30, 1647–1652.
26.Deurenberg, P, Yap, M & van Staveren, WA (1998) Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 22, 1164–1171.
27.Dale, CE, Fatemifar, G, Palmer, TM, et al. (2017) Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation 135, 2373–2388.
28.Smith, GD & Ebrahim, S (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32, 1–22.
29.Day, K, Kwok, A, Evans, A, et al. (2018) Comparison of a bioelectrical impedance device against the reference method dual energy X-ray absorptiometry and anthropometry for the evaluation of body composition in adults. Nutrients 10, E1469.
30.Hamdy, O, Porramatikul, S & Al-Ozairi, E (2006) Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2, 367–373.
31.Anand, SS, Tarnopolsky, MA, Rashid, S, et al. (2011) Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS ONE 6, e22112.
32.Cheng, YH, Tsao, YC, Tzeng, IS, et al. (2017) Body mass index and waist circumference are better predictors of insulin resistance than total body fat percentage in middle-aged and elderly Taiwanese. Medicine (Baltimore) 96, e8126.
33.Xin, Y, Davies, A, McCombie, L, et al. (2018) Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes. Lancet Diabetes Endocrinol 7, 169–172.
34.Taylor, R (2016) Calorie restriction and reversal of type 2 diabetes. Diabetes Care 11, 521–528.
35.McCombie, L, Leslie, W, Taylor, R, et al. (2017) Beating type 2 diabetes into remission. BMJ 358, j4030.
36.Taylor, R (2013) Type 2 diabetes: etiology and reversibility. Diabetes Care 36, 1047–1055.
37.Taylor, R (2013) Banting Memorial Lecture 2012: Reversing the twin cycles of type 2 diabetes. Diabetic Med 30, 267–275.
38.Chan, Z, Ding, C, Chooi, YC, et al. (2019) Ectopic fat and aerobic fitness are key determinants of glucose homeostasis in nonobese Asians. Eur J Clin Invest 49, e13079.
39.Kapoor, N, Audsley, J, Rupali, P, et al. (2019) A gathering storm: HIV infection and non-alcoholic fatty liver disease in low and middle-income countries. AIDS 33, 1105–1115.
40.Stevens, J, Couper, D, Pankow, J, et al. (2001) Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 9, 696–705.
41.Rajput, R, Rajput, M, Bairwa, M, et al. (2014) Waist height ratio: a universal screening tool for prediction of metabolic syndrome in urban and rural population of Haryana. Indian J Endocrinol Metab 18, 394–399.
42.Sathish, T, Kannan, S, Sarma, SP, et al. (2013) Screening performance of diabetes risk scores among Asians and whites in rural Kerala, India. Prev Chronic Dis 10, E37.
43.Yusuf, S, Hawken, S, Ounpuu, S, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952.